MANUEL A. PENALVER, MD

Plain English
This study looked at how insurance affects access to prenatal care for pregnant women in South Florida. Researchers found that only 45.1% of doctors accepted Medicaid, compared to nearly all doctors accepting private insurance like Cigna (98.6%) and UnitedHealthcare (97.2%). Additionally, women on Medicaid had to wait an average of 17 days for appointments, compared to 12.7 days for those with UnitedHealthcare. This matters because limited access to care for Medicaid patients can lead to worse health outcomes for mothers and babies. Who this helps: Medicaid patients seeking prenatal care.

Plain English
This study looked at patients with blood disorders who needed emergency surgery for abdominal problems between 1998 and 2013. Out of 58 patients, 19 had surgery while their immune systems were weak due to low white blood cell counts. The researchers found that having surgery after 2002 reduced the risk of death significantly, while being in septic shock or needing dialysis increased the risk of dying in the hospital. This matters because it shows that timely surgery can lead to better outcomes for these patients, even when they have low blood cell counts. Who this helps: This helps hematology patients and their doctors make informed decisions about emergency surgeries.

Plain English
Researchers developed a new test called the microculture-kinetic (MiCK) assay to measure how well cancer treatments cause cancer cell death, or apoptosis. In clinical trials, patients with acute myelocytic leukemia and epithelial ovarian cancer who received treatments identified as effective by this test had a 50% higher response rate and survived longer compared to those who did not. This test could lead to more personalized treatment plans, potentially saving costs and speeding up the approval of new drugs. Who this helps: This helps cancer patients and doctors tailoring treatments.

Plain English
This study looked at whether a specific test, called the MiCK assay, could help predict which chemotherapy would work best for patients with ovarian cancer. Researchers found that for patients with Stage III or IV ovarian cancer, those who received the most effective chemotherapy based on the MiCK test had significantly longer overall survival (hazard ratio of 0.23) and better outcomes compared to those who did not receive the best treatment identified by the test. Specifically, survival was longer (p < 0.01) and the time without relapse was also extended (p = 0.03) for patients given the best chemotherapy identified by the MiCK assay. Who this helps: This helps ovarian cancer patients by potentially increasing their chances of survival and reducing recurrence through better treatment choices.

Plain English
This study looked at how effective extensive testing for infections was in women developing fevers after common gynecologic surgeries, focusing on data from 505 patients treated between 1994 and 2000. Out of the 147 patients who met the fever criteria, only a small percentage had actual infections—9.7% showed positive blood cultures, 18.8% for urine cultures, and 14% for chest X-rays. These findings suggest that the extensive testing may not be necessary for all patients, prompting a need to customize fever evaluations based on individual cases. Who this helps: This helps doctors make better decisions regarding testing for infections in women after surgery.

Plain English
This study looked at how to improve treatments for invasive cervical cancer, which can spread through the body. It found that combining surgeries like hysterectomy with advanced imaging and chemotherapy can help choose the best therapies, especially for women who want to keep their ability to have children. The research points to the need for better tests and treatments to improve outcomes for patients facing this serious disease. Who this helps: Patients with invasive cervical cancer, particularly those who want to preserve their fertility.

Plain English
This study explored two surgical techniques—continent urinary diversion (specifically the Miami Pouch) and low colorectal anastomosis—used in women who had a pelvic exenteration, a major surgical procedure for cancer treatment. The research found that out of 77 patients, complicated urinary issues occurred in about 22% of cases, while 35% of patients who had received radiation therapy experienced serious complications after the colorectal surgery, compared to only 7.5% in those who had not been irradiated. These findings highlight the importance of careful patient selection and counseling, especially for those who have undergone radiation, to help manage complications and improve quality of life after such surgeries. Who this helps: This benefits women undergoing pelvic exenteration for cancer treatment.

Plain English
This study focused on how to effectively treat vesicovaginal fistulas, which can occur after gynecological surgeries and affect over 1% of patients undergoing such procedures. The findings showed that a vaginal repair technique has a high success rate, ranging from 70% to 100% for patients without previous radiation treatment, with an average success rate of 91%. The research emphasizes that waiting 4-6 weeks after a fistula develops before attempting repair is important, and this approach typically leads to fewer complications and shorter recovery times. Who this helps: This benefits patients who experience vesicovaginal fistulas after surgery.

Plain English
This study looked at a rare type of tumor called malignant peripheral nerve sheath tumor (MPNST) that occurred in the vulva of a 34-year-old woman. She had a large tumor, measuring 20 by 20 centimeters, which was causing pain and mobility issues. After treatment that included surgery and radiation, it was suggested that patients with this type of tumor should undergo complete surgical removal along with radiation and chemotherapy to improve outcomes. Who this helps: This benefits patients diagnosed with malignant peripheral nerve sheath tumors in the vulva.

Plain English
This study looked at how radical vaginal trachelectomy (RVT) can be safely used for certain patients with early stage cervical cancer, especially those who have had a partial hysterectomy in the past. Researchers found that RVT was successful in treating an 81-year-old woman with cervical cancer, allowing her to recover without complications. This matters because RVT is less invasive and helps maintain fertility, providing a valuable treatment option for patients who might not tolerate more invasive surgeries. Who this helps: This helps women with early stage cervical cancer, especially those who have had a supracervical hysterectomy.

Plain English
This study looked at how often vulvar cancer comes back after treatment, finding that about 24% of patients experience a recurrence, particularly close to the original tumor site or in the lymph nodes. The research highlighted that surgery remains the main treatment, but using radiation and chemotherapy together has been successful in improving outcomes, especially for patients who can't have surgery. This matters because it provides better treatment options for patients with advanced vulvar cancer, potentially leading to fewer complications and improved survival rates. Who this helps: Patients with recurrent vulvar cancer.

Plain English
This study looked at the levels of a protein called glucose transporter-1 (GLUT 1) in different stages of cervical cancer and its early forms. Researchers found that every single case (100%) of invasive cervical cancer showed high levels of GLUT 1, and that the intensity of this expression was linked to how severe the tumor was. This matters because it indicates that GLUT 1 overexpression happens later in the cancer development process, which may help in understanding tumor behavior and could guide treatment strategies. Who this helps: This benefits patients with cervical cancer and their doctors by providing insight into tumor characteristics.

Plain English
This study looked at different ways to manage urinary function in women who have undergone surgery for gynecologic cancers or other urinary problems. The researchers found that the Miami pouch, a type of continent urinary diversion created from the colon, has been used since 1988 with generally good outcomes. Continent pouches may involve a few risks but can significantly improve quality of life, allowing women to avoid external bags used with other methods. Who this helps: This benefits women facing urinary diversion after cancer surgery.

Plain English
This study looked at how a protein called GLUT-1 affects the treatment and survival of patients with ovarian cancer. Researchers found that 85.6% of the cancer tumors tested had high levels of GLUT-1, and those with higher levels were more likely to respond well to chemotherapy (80% responded completely compared to 51.5% of those without high GLUT-1). Additionally, patients with very high GLUT-1 levels experienced a shorter time without disease progression, with an average of 30 months compared to 60 months for those with lower levels. Who this helps: This research benefits ovarian cancer patients and their doctors by providing insights into treatment responses and survival expectations.

Plain English
This study investigated a new treatment called 2-gluSNAP, which combines glucose with a nitric oxide-releasing molecule, to see if it could effectively kill ovarian cancer cells. The findings showed that 2-gluSNAP was about 5,000 times more effective at killing a type of ovarian cancer cell than the original nitric oxide donor alone, with median effective doses of 0.0042 microM for 2-gluSNAP compared to 20.4 microM for the original compound in sensitive cancer cells. This is important because it means that 2-gluSNAP could be a promising targeted therapy for ovarian cancer, which has cells that express high levels of glucose transport proteins. Who this helps: This benefits patients with ovarian cancer.

Plain English
This study looked at a protein called GLUT-1, which helps cancer cells use more sugar than normal cells, in ovarian tumors. Researchers found that 98.8% of malignant ovarian tumors had high levels of GLUT-1, compared to 95.2% of borderline tumors, with malignant tumors showing significantly stronger GLUT-1 staining than borderline ones. This is important because it indicates that higher GLUT-1 levels are linked to more aggressive cancers, which could help in assessing tumor severity and guiding treatment. Who this helps: This helps doctors and patients by providing insights into tumor behavior and potential treatment strategies.

Plain English
This study looked at how often complications occurred in patients who had surgery to remove cancer from the pelvis and needed to reconnect parts of their colon that were surgically separated. Among 77 patients, researchers found that 30% of those who had received prior radiation treatment developed issues with their surgery connections, compared to only 7.5% of those who hadn’t had radiation. This is important because it highlights that patients who have been treated with radiation are at a significantly higher risk for complications, which can impact their recovery and future treatment options. Who this helps: This helps patients who have undergone pelvic radiation and their doctors.

Plain English
This research discussed a rare form of cancer called primary melanoma of the cervix, which has only been reported in 26 cases. Most patients, aged between 26 and 78, experienced vaginal bleeding, and about 88% were diagnosed in the early stages (I or II). The case reported involved a patient with stage IIa melanoma who had surgery and additional treatment, surviving for 29 months after diagnosis; however, the outlook for this type of cancer is usually poor. Who this helps: This information helps doctors treating patients with cervical melanoma.

Plain English
This study looked at a rare type of cancer called primary uterine angiosarcoma, specifically in a Hispanic American woman. The researchers found that out of 19 reported cases, most patients (74%) were around 55 years old and experienced symptoms like pelvic masses and heavy bleeding. Unfortunately, only 43% of patients survived after one year, and there is no clear best treatment since this cancer tends to come back quickly and is generally very aggressive. Who this helps: This information is useful for doctors and healthcare providers managing care for patients with this rare cancer.

Plain English
This study looked at the best sequence for performing surgery on women with early-stage cervical cancer, specifically whether to do a radical hysterectomy or lymph node removal first. Researchers analyzed data from 314 patients and found that both sequences were equally safe, with no major differences in complications. However, patients who had a hysterectomy first spent less time in the hospital (8 days vs. 10 days) and the surgery took longer if lymph nodes were removed first (230 minutes vs. 172 minutes). Who this helps: This helps patients with cervical cancer by offering surgical options with similar safety and outcomes.

Plain English
This study looked at a specific type of surgical cut, called the Pfannenstiel incision, used during a major surgery for patients with early-stage cervical cancer. Researchers reviewed the outcomes of 25 patients who had this surgery and found that the operation time and blood loss were normal, and there were very few complications afterward—none related to the wound. This is important because it shows that this surgical approach can be effective and safer for certain patients compared to more traditional methods. Who this helps: Patients undergoing surgery for cervical cancer.

Plain English
This study looked at a surgical procedure called transvaginal sacrospinous ligament fixation, which is used to fix pelvic support problems in women. Out of 160 women who had the surgery, 94% showed no signs of a problem with their vaginal vault afterward, and 85% did not experience a recurrence of pelvic issues within an average follow-up of over three years. This is important because it shows the procedure is both safe and effective, suggesting that medical residents should be trained to perform it. Who this helps: This helps patients with pelvic support defects.

Plain English
This study looked at the results of tests done using fluid collected from the abdominal cavity during surgery to remove the uterus in 400 women with cervical cancer. It found that only 1.8% of these tests were positive for cancer cells, and most of those women had larger tumors and a high chance of the cancer coming back within 18 months. The findings show that these tests didn’t provide any extra information that could help doctors make better treatment decisions. Who this helps: This helps doctors and patients understand the limited benefit of abdominal fluid tests during cervical cancer surgeries.

Plain English
This study looked at 1,223 patients with early-stage cervical cancer who had a radical hysterectomy between 1965 and 1995. It found that 51 of these patients had close vaginal margins, meaning cancer cells were very near the edge of the tissue that was removed. Those who received additional radiation therapy after surgery had a much higher 5-year survival rate of 81.3%, compared to just 28.6% for those who did not get radiation, also experiencing fewer recurrences of cancer. Who this helps: This helps cervical cancer patients and their doctors make better decisions about post-surgery treatments.

Plain English
This paper studied hereditary and sporadic ovarian cancer, focusing on genetic mutations linked to the disease, particularly in genes like BRCA1 and BRCA2. It found that hereditary forms of ovarian cancer often involve these mutations, while sporadic cases may also involve other genes related to DNA repair. Understanding these genetic factors is crucial because it can lead to better screening and personalized treatment options for people at risk of ovarian cancer. Who this helps: Patients with a family history of ovarian cancer and their doctors.

Plain English
This study looked at how to manage urinary problems that can occur after a surgery called the Miami pouch, which is used for bladder reconstruction. Researchers found that 80% of complications related to this procedure could be successfully treated with non-surgical methods, while only 16.9% needed additional surgery. This is important because it shows that less invasive treatments can often resolve issues, reducing patient risk, especially considering that reoperations have a high mortality rate of 11.7%. Who this helps: This helps patients who have undergone the Miami pouch surgery.

Plain English
This study looked at a rare type of skin cancer called malignant melanoma that occurs in the cervical area of the uterus. The case involved a 70-year-old woman who had irregular vaginal bleeding and was treated with surgery and radiation, ultimately living for about 29 months after her diagnosis. Out of 24 cases reviewed, most patients showed signs of this cancer between the ages of 39 and 78, with vaginal bleeding being the most common symptom, reported by 67% of those affected. Who this helps: This research helps patients diagnosed with cervical melanoma and their doctors understand treatment options and survival outcomes.

Plain English
This study looked at a rare case of molar pregnancy in a 51-year-old woman who experienced prolonged vaginal bleeding. After a pelvic ultrasound confirmed the diagnosis, she underwent surgery and received five treatments with a specific chemotherapy drug due to high levels of a pregnancy hormone that weren't decreasing as expected. This research highlights the importance of recognizing unusual forms of pregnancy complications in older patients, which can lead to faster diagnosis and treatment. Who this helps: This helps older women experiencing unusual pregnancy symptoms and the doctors treating them.

Plain English
This study looked at a rare case of a pregnant woman diagnosed with advanced colorectal cancer, specifically mucinous adenocarcinoma, after an ultrasound revealed a mass in her abdomen. The doctors found that while they suspected the mass might be from the ovaries, it turned out to be metastatic cancer, and the diagnosis was ultimately confirmed during surgery. This is important because it highlights the need for careful monitoring and timely treatment for pregnant patients with similar issues, ensuring that their health is prioritized without unnecessary delays. Who this helps: This benefits pregnant patients who may have similar health concerns.

Plain English
This study examined a rare case of a woman who became pregnant in both her left fallopian tube and right interstitial part of her uterus at the same time. The doctors found it challenging to diagnose this type of pregnancy, which is called bilateral ectopic pregnancy, using standard methods like ultrasound and laparoscopy. This matters because understanding these rare pregnancies can improve diagnosis and treatment for women facing similar complications. Who this helps: This helps patients who experience ectopic pregnancies and the doctors treating them.

Plain English
This study looked at how a new drug called lonidamine (LND) could enhance the effects of existing chemotherapy drugs cisplatin and carboplatin on ovarian cancer cells that are resistant to platinum-based treatments. The researchers found that when LND was used alongside these drugs, it significantly increased their ability to kill cancer cells, particularly at doses of 20 and 30 µg/ml. This is important because it offers a potential new option for treating patients with difficult-to-treat ovarian cancer. Who this helps: This helps ovarian cancer patients, especially those whose cancer doesn't respond to standard platinum treatments.

Plain English
This study looked at the use of laparoscopic surgery, a minimally invasive technique, in treating gynecological cancers. It found that while laparoscopy has become common in other areas of gynecology, it is still not widely used by cancer specialists, and its applicability to all patients with gynecological cancers may not be appropriate. As surgical technology improves, laparoscopy might become suitable for more procedures, but it's important to evaluate these changes carefully through research. Who this helps: Patients with gynecological cancers who may benefit from less invasive surgery options.

Plain English
This study looked at the medical records and tumor samples of 62 patients with uterine sarcoma diagnosed between 1978 and 1988 to understand factors that could predict their survival outcomes. Researchers found that surgical staging was the most important factor for survival, with patients classified as Stage I having a much better outlook compared to those at later stages. Specifically, patients with diploid tumors had a 5-year survival rate of 72%, while those with hyperdiploid and hypodiploid tumors had median survival rates of only 18 and 12 months, respectively. Who this helps: This research benefits doctors and patients with uterine sarcomas by improving their understanding of survival chances based on tumor characteristics and staging.

Plain English
This study looked at using ultrasound to help remove ureteral catheters in women, which are tubes placed to help urine flow. Researchers removed six catheters from five patients, taking an average of about 12 minutes for each removal, and patients generally felt good about the process. This method is important as it may lead to a safer and more comfortable way for women to have these catheters removed. Who this helps: This benefits women who need ureteral catheters and the doctors who perform their removal.

Plain English
In this study, researchers looked at the complications that occurred in 39 patients who underwent a specific surgical procedure to create a new way for urine to be stored after their bladder was removed. They found that 18 patients (46%) had early complications, and three of these patients died as a result, giving an overall mortality rate of 7%. Additionally, 6 patients (15%) faced complications later on, but only one needed further surgery because of these issues. Who this helps: This information helps doctors and healthcare teams improve care for patients undergoing urinary diversion surgery.